We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVF
4901
INVO Fertility Inc
IVF
$1.73M
– –
0
– –
IRD
4902
Opus Genetics
IRD
$309M
$6K ﹤0.01%
1,721
-3,382
-66% -$12.1K
CIRC
4903
Circle8 Group
CIRC
$61.2M
$6K ﹤0.01%
347
+32
+10% +$727
TBCH
4904
Turtle Beach Corp
TBCH
$230M
$6K ﹤0.01%
623
-19,330
-97% -$164K
MCAA
4905
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$6K ﹤0.01%
605
+99
+20% +$1.04K
BTCY
4906
DELISTED
Biotricity, Inc. Common Stock
BTCY
$6K ﹤0.01%
2,321
+382
+20% +$1.57K
DYNT
4907
DELISTED
Dynatronics Corp
DYNT
$6K ﹤0.01%
4,035
+2,541
+170% +$5.11K
TCON
4908
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$6K ﹤0.01%
167
-259
-61% -$8.49K
RWODU
4909
DELISTED
Redwoods Acquisition Corp. Unit
RWODU
$6K ﹤0.01%
552
– –
AFIB
4910
DELISTED
Acutus Medical Inc
AFIB
$6K ﹤0.01%
7,772
+7,694
+9,864% +$10K
VINO
4911
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$6K ﹤0.01%
66
-21
-24% -$2.8K
BTTX
4912
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$6K ﹤0.01%
9,146
+2,636
+40% +$3.1K
ADEX.U
4913
DELISTED
Adit EdTech Acquisition Corp Units
ADEX.U
$6K ﹤0.01%
613
– –
VAPO
4914
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$6K ﹤0.01%
+1,078
New +$10K
APGN
4915
DELISTED
Apexigen, Inc. Common Stock
APGN
$6K ﹤0.01%
11,758
+1,450
+14% +$1.74K
EVLO
4916
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$6K ﹤0.01%
1,616
+1,350
+508% +$20.8K
STSA
4917
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$6K ﹤0.01%
+8,280
New +$7.62K
LABP
4918
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$6K ﹤0.01%
2,126
+352
+20% +$1.3K
APTX
4919
DELISTED
Aptinyx Inc. Common Stock
APTX
$6K ﹤0.01%
46,312
+19,217
+71% +$7K
PEAR
4920
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$6K ﹤0.01%
22,982
+14,039
+157% +$12.7K
ISEM
4921
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Emerging Markets ETF
ISEM
$6K ﹤0.01%
+254
New +$6.14K
KRBP
4922
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$6K ﹤0.01%
1,559
+1,403
+899% +$7.42K
AFARU
4923
DELISTED
Aura FAT Projects Acquisition Corp Unit
AFARU
$6K ﹤0.01%
519
– –
AFBI
4924
DELISTED
Affinity Bancshares
AFBI
$5K ﹤0.01%
+377
New +$5.64K
CHGA
4925
Change Agents Corporation Common Stock
CHGA
$2.94M
$5K ﹤0.01%
162
+65
+67% +$2.93K
195 196
197
198 199

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.